Drug resistance in intensive care units

Infection

Volumn 27, Issue SUPPL. 2, 1999, Pages

  Albrich, W C ^b   Angstwurm, M ^b   Bader, L ^a   Gartner R ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL INFECTION; CONFERENCE PAPER; HOSPITAL INFECTION; HUMAN; INFECTION RISK; INTENSIVE CARE UNIT; MORBIDITY; MORTALITY; PRACTICE GUIDELINE; QUALITY CONTROL; RESPIRATORY TRACT INFECTION; RISK FACTOR;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE; GERMANY; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; MICROBIAL SENSITIVITY TESTS; RISK FACTORS;

EID: 0032824499     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02561665     Document Type: Conference Paper

References (33)

1. Vincent, J. L., Bihari, D. J., Suter, P. M., Bruining, H. A., White, J., Nicolas-Cahnoi, M. H., Wolff, M., Spencer, R. C., Hemmer, M., for the EPIC International Advisory Committee: The prevalence of nosocomial infection in intensive care units in Europe. Results of the European prevalence of infection in intensive care (EPIC) study. JAMA 274 (1995) 639-644.
2. Richards, M. J., Edwards, J. R., Culver, D. H., Gaynes, R. P., the National Nosocomial Infections Surveillance System: Nosocomial infections in coronary care units in the United States. Am. J. Cardiol. 82 (1998) 789-793.
3. Craven, D. E., Kunches, L. M., Lichtenberg, D. A., Kollisch, N. R., Barry, A., Heeren, T. C., McCabe, W. R.: Nosocomial infection and fatality in medical and surgical intensive care unit patients. Arch. Intern. Med. 148 (1988) 1161-1168.
4. Namias, N., Harvill, S., Ball, S., McKenney, M. G., Salomone, J. P., Sleeman, D., Civetta, J. M.: Empiric therapy of sepsis in the surgical intensive care unit with broad-spectrum antibiotics for 72 hours does not lead to the emergence of resistant bacteria. J. Trauma 45 (1998) 887-891.
5. Wheeler, A. P., Bernard, G. R.: Treating patients with severe sepsis. N. Engl. J. Med. 340 (1999) 207-214.
6. Lucet, J. C., Chevret, S., Decre, D.: Outbreak of multiply resistant Enterobacteriaceac in an intensive care unit: epidemiology and risk factors for acquisition. Clin. Infect. Dis. 22 (1996) 430-436.
7. Quínn, J. P.: Clinical problems posed by nonfermenting gram-negative pathogens. Clin. Infect. Dis. 27 (Suppl. 1) (1998) 117-124.
8. Jarlier, V., Fosse, T., Philippon, A., ICU Study Group: Antibiotic susceptibility in acrobic gram-negative bacilli isolated in intensive care Units in 39 French teaching hospitals (ICU study). Intensive Care Med. 22 (1996) 1057-1065.
9. McGowan, J., Tenover, F.: Antimicrobial resistance in the intensive care unit: impact of new patterns. Int. J. Clin. Pract. (Suppl. 95) (1998) 14-22.
10. Drusano, G. L.: Infection in the intensive care unit: β-lactamase-mediated resistance among Enterobacteriaceae and optimal antimicrobial dosing. Clin. Infect. Dis. 27 (Suppl. 1) (1998) 111-116.
11. Piroth, L., Aube, H., Doise, J. M., Vincent-Martin, M.: Spread of extended-spectrum β-lactamase-producing Klebsiella pneumoniae: are β-lactamase inhibitors of therapeutic value? Clin. Infect. Dis. 27 (1998) 76-80.
12. Spencer, R. C., for the International Study Group: Cross-susceptibility of cefpironte and four other β-lactams against isolates from haematology/oncology and intensive care units. Scand. J. Infect. Dis. (Suppl. 91) (1993) 25-32.
13. Ibelings, M. M., Bruining, H. A.: Methicillin-resistant Staphylococcus aureus: acquisition and risk of death in patients in the intensive care unit. Eur. J. Surg. 164 (1998) 411-418.
14. Conterno, L. O., Wey, S. B., Castelo, A.: Risk factors for mortality in Staphylococcus aureus bacteremia. Infect. Control Hosp. Epidemiol. 19 (1998) 32-37.
15. Harbarth, S., Rutschmann, O., Sudre, P., Pittet, D.: Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus. Arch. Intern. Med. 26 (1998) 182-189.
16. Mainous, M. R., Lipsett, P. A., O'Brien, M.: Enterococcal bacteremia in the surgical intensive care unit. Does vancomycin resistance affect mortality? The Johns Hopkins SICU Study Group. Arch. Surg. 132 (1997) 76-81.
17. Edmond, M. B., Ober, J. F., Dawson, J. D., Weinbaum, D. L., Wenzel, R. P.: Vancomycin-resistant enterococcal bacteremia: natural history and attributable mortality. Clin. Infect. Dis. 23 (1996) 1234-1239.
18. Snydman, D. R.: Clinical implications of multi-drug resistance in the intensive care unit. Scand. J. Infect. Dis. (Suppl. 78) (1991) 54-63.
19. Alvarez-Lerma, F., ICU-Acquired Pneumonia Study Group: Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. Intensive Care Med. 22 (1996) 387-394.
20. Moellering, R. C. Jr.: Antibiotic resistance. Lessons for the future. Clin. Infect. Dis. 27 (Suppl. 1) (1998) 135-140.
21. Kollef, M. H., Vlasnik, J., Sharpless, L., Pasque, C., Murphy, D., Fraser, V.: Scheduled change of antibiotic classes: a strategy to decrease the incidence of ventilator-associated pneumonia. Am. J. Respir. Crit. Care Med. 156 (1997) 1040-1048.
22. Nathans, A. B., Marshall, J. C.: Selective decontamination of the digestive tract in surgical patients: a systematic review of the evidence. Arch. Surg. 134 (1999) 170-176.
23. The Erlanger Silver Catheter: Infection Suppl. 1 (1999) 1-80.
24. Darouiche, R. O., Raad, I. I., Heard, S. O., Thornby, J. I, Wenker, O. C., Gabrielli, A., Berg, J., Khardori, N., Hanna, H., Hachem, R., Harris, R. L., Mayhall, G. for the Catheter Study Group: A comparison of two antimicrobial-impregnated central venous catheters. N. Engl. J. Med. 340 (1999) 1-8.
25. Spencer, R. C.: Predominant pathogens found in the European Prevalence of Infection in Intensive Care Study. Eur. J. Clin. Microbiol. Infect. Dis. 15 (1996) 281-285.
26. Tornieporth, N. G., Roberts, R. B., John, J., Hafner, A., Riley, L. W.: Risk factors associated with vancomycin-resistant Enterococcus faecium infection or colonization in 145 matched case patients and control patients. Clin. Infect. Dis. 23 (1996) 767-772.
27. Slaughter, S., Hayden, M. K., Nathan, C., Hu, T. C., Rice, T., v. Voorhis, J., Matushek, M., Franklin, C., Weinstein, R. A.: A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit. Ann. Intern. Med. 125 (1996) 448-456.
28. Bonten, M. J. M., Slaughter, S., Hayden, M. K., Nathan, C., v. Voorhis, J., Weinstein, R. A.: External sources of vancomycin-resistant enterococci for intensive care units. Crit. Care Med. 26 (1998) 2001-2004.
29. Doebbeling, B. N., Stanley, G. L., Sheetz, C. T., Pfaller, M. A., Houston, A. K., Annis, L., Li, L., Wenzel, R. P.: Comparative efficacy of alternative hand-washing agents in reducing nosocomial infections in intensive care units. N. Engl. J. Med. 327 (1992) 88-93.
30. Moellering, R. C. Jr.: Interaction between antimicrobial consumption and selection of resistant bacterial strains. Scand. J. Infect. Dis. 70 (Suppl.) (1990) 18-24.
31. McGowan, J. E. Jr.: Do intensive hospital antibiotic control programs prevent the spread of antibiotic resistance? Infect. Control Hosp. Epidemiol. 15 (1994) 478-483.
32. Dagan, O., Cox, P. N., Ford-Jones, L., Ponsonby, J., Bohn, D. J.: Nosocomial infection following cardiovascular surgery: comparison of two periods, 1987 vs. 1942. Crit. Care Med. 27 (1999) 104-108.
33. Evans, R. S., Pestotnik, S. L., Classen, D. C., Clemmer, T. P., Weaver, L. K., Orme, J. F., Lloyd, J. F., Burke, J. P.: A computer-assisted management program for antibiotics and other antiinfective agents. N. Engl. J. Med. 338 (1998) 232-238.